Figure 1From: Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents Specific information of study population, allocation and withdrawal in present clinical study. Back to article page